Moreover, in mouse models, increased decorin levels in cerebrospinal fluid (CSF) have been shown to be associated with early formation of Aβ amyloidosis and has therefore been proposed as an early biomarker for detection of Alzheimer ́s disease [44]. This evidence concerns the gene DCN and Alzheimer disease.